Regional Heterogeneity of the Results of Glucagon-Like Peptide 1 Receptor Agonist Trials in Type 2 Diabetes: A Reanalysis of Individual Participant Data.
2型糖尿病中胰高血糖素樣肽-1受體激動劑試驗結果的區域異質性：個別參與者數據的再分析。
Diabetes Care 2024-08-27
Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitus.
糖尿病亞洲人與白人患者使用胰高血糖素樣肽-1受體激動劑和鈉-葡萄糖共轉運輸蛋白-2抑制劑對心血管和腎臟結果的影響。
Diabetes Metab Syndr 2023-07-18
Ethnic/Racial and Geographic Disparities on Major Cardiovascular Events in Glucagon Like Peptide-1 receptor Agonists Trials: A Meta-Analysis.
GLP-1 受體激動劑試驗中主要心血管事件的族裔/種族和地理差異：一項荟萃分析。
Curr Probl Cardiol 2023-12-16
[Efficacy of treatment with glucagon-like peptide receptor agonists-1 in Asian patients with type 2 diabetes mellitus].
亞洲糖尿病患者使用 GLP-1 受體激動劑治療的療效。
Probl Endokrinol (Mosk) 2023-11-16
Racial, ethnic and regional differences in the effect of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes: a systematic review and meta-analysis of cardiovascular outcome trials.
鈉葡萄糖共同轉運蛋白2抑製劑和葡萄糖樣肽1受體激動劑對心血管和腎臟結果的影響：心血管結果試驗的系統性回顧和荟萃分析中的種族、民族和地區差異。
J R Soc Med 2024-04-22
Comparison of GLP-1 receptor agonists and other Glucose-Lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and Obesity: A Spanish Real-World Population-Based study.
GLP-1受體激動劑與其他降糖藥物在2型糖尿病和肥胖患者心血管結果上的比較：西班牙真實世界人口研究。
Diabetes Res Clin Pract 2024-02-16
Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia.
澳洲新南威爾士地區 2 型糖尿病患者中鈉葡萄糖共同轉運蛋白 2 抑制劑和葡萄糖樣肽-1 受體激動劑使用的地理變異。
Diabetes Obes Metab 2024-04-15
Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials.
糖尿病患者和非糖尿病患者中胰高血糖素樣肽-1受體激動劑的心血管和腎臟結果：隨機安慰劑對照試驗的荟萃分析。
Am J Prev Cardiol 2024-05-23
Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes mellitus: A meta-analysis of placebo-controlled randomized controlled trials.
糖尿病患者和非糖尿病患者中胰高血糖素樣肽-1受體激動劑對主要不良心血管結果的性別、種族、民族和地理差異：對安慰劑對照隨機對照試驗的荟萃分析。
J Clin Lipidol 2024-06-21
Glucagon-Like Peptide-1 Receptor Agonists and Major Adverse Cardiovascular Events in Patients With and Without Diabetes: A Meta-Analysis of Randomized-Controlled Trials.
糖尿病患者和非糖尿病患者中胰高血糖素樣肽-1受體激動劑與主要不良心血管事件：隨機對照試驗的荟萃分析。
Clin Cardiol 2024-07-02